Development of THALEA Kit and Its Impact on Knowledge, Attitude, and Intention for Premarital Thalassemia Screening
NCT06800495 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 148
Last updated 2025-01-30
Summary
Thalassemia, a common genetic disease, is often overlooked compared to infectious diseases like HIV, despite its significant effects for families planning to have children. Thalassemia carriers are frequently asymptomatic, but when two carriers marry, there is a 25% chance of having a child with a severe form of the disease. Although screening programs exist, the number of symptomatic thalassemia major continues to increase, and current treatments are primarily symptomatic, merely prolonging survival rather than curing it.
In Malaysia, while HIV testing before marriage is mandatory, thalassemia screening is not. Presently, thalassemia screening and awareness programs are offered to fourth-form students in government schools only. Hence, there is a need to complement existing national screening efforts by creating a standardized thalassemia awareness program that can be effectively implemented across diverse educational institutions.
Our main objective is to develop and validate the THALEA (Thalassemia education and awareness) kit and evaluate its effectiveness among secondary school students in Klang Valley, Malaysia. We hope that with this intervention, high school students are be able to increase their awareness and knowledge, instil a positive attitude and have that intention to do a pre-marital thalassemia screening at any healthcare facility in our country. This can facilitate early detection and timely counselling to reduce the risk of having children with severe thalassemia.
Delivery of the intervention:
i. Schools will be approached by letter, followed by a phone call and a visit. ii. Consent forms will be given for parents to sign. iii. All fourth form students at the school will be invited to participate in the study, excluding those who meet the exclusion criteria.
iv. THALEA will be delivered by a face-to-face method between the main researcher and the students.
v. Frequency of delivery - one time only vi. Duration of intervention - 2-3 hours. vii. The intervention group will receive THALEA along with a basic family health education. THALEA's session comprises a face-to-face verbal presentation facilitated by the primary researcher, featuring an engaging interactive seminar and on-screen games. Following this, participants will be presented with 3-5-minute videos and pictorial materials, fostering two-way discussions. Subsequently, a softcopy of the THALEA kit will be distributed to the teacher in charge via email or WhatsApp after the seminar for further dissemination. The students will receive THALEA's brochures.
viii. The comparison group will only receive a basic family health education in which it is the usual family health education given by the MOH, usually delivered by a medical officer, to fourth form students at government schools prior to the thalassemia screening programme. It will consist of a delivery of a PowerPoint presentation and videos, that will be obtained from government public health clinics in Klang Valley.
We will use a self-administered questionnaire designed and validated to assess knowledge, attitude, and intention regarding premarital thalassemia screening among youths at three different time points which are during pre-assessment (t0), immediate post-assessment (t1), and 2 weeks post assessment (t2)
Conditions
Interventions
- BEHAVIORAL
-
THALEA (Thalassemia Education and Awareness) Kit
By using the opinions obtained by the experts, THALEA's content will then be designed using the Theory of Planned Behaviour (TPB) by Ajzen and Fishbein. Development of THALEA: • Language: Malay and English. • Contents of the THALEA kit: i. PowerPoint or Canva presentations with discussion prompts (softcopy form) ii. Links/joining codes to free educational game platforms such as Kahoot or Quizziz iii. Videos - convey messages on thalassemia awareness and screening importance. iv. Illustrated guides/brochures - to provide step-by-step tutorials on how to get thalassemia screening in both the public and private healthcare. • Developer would be the main researcher with aid from: i. Illustrator ii. Video graphic designer iii. Influencers • Delivery of THALEA to students by: i. Medical personnel
- BEHAVIORAL
-
Basic thalassemia and family health education
They are basic family health education in which it is the usual family health education given by the MOH, usually delivered by a medical officer, to fourth form students at government schools prior to the thalassemia screening programme. It will consist of a delivery of a PowerPoint presentation and videos, that will be obtained from government public health clinics in Klang Valley.
Sponsors & Collaborators
-
Universiti Teknologi Mara
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 15 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-10-01
- Primary Completion
- 2025-10-31
- Completion
- 2025-12-31
Countries
- Malaysia
Study Locations
More Related Trials
-
Screening for Alpha Thalassemia in Healthy Volunteers
NCT02692872 ·Status: ACTIVE_NOT_RECRUITING
-
Thalassemia Screening by Third Generation Sequencing
NCT05552690 ·Status: UNKNOWN ·Phase: NA
-
Detection of β Thalassemia Carriers by Red Cell Parameters Obtained From the H2 Automatic Counter
NCT00481221 ·Status: UNKNOWN
-
Sexual Maturation in β-Thalassemia Major Patients in Assiut University Hospital
NCT03847558 ·Status: UNKNOWN
-
An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease
NCT04688411 ·Status: RECRUITING ·Phase: NA
-
Assessment of Cognitive Function and Quality of Life in Thalassemic Children at Sohag University Hospital
NCT06058260 ·Status: NOT_YET_RECRUITING
-
Clinical Study of CN128 in Thalassemia Patients
NCT03673085 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Pain in People With Thalassemia
NCT00872339 ·Status: COMPLETED
-
Evaluation of Low-cost Techniques for Detecting Sickle Cell Disease and β-thalassemia in Nepal and Canada
NCT05506358 ·Status: COMPLETED ·Phase: NA
-
Thalassaemia Severity
NCT06720480 ·Status: NOT_YET_RECRUITING
-
B-Thalasaemia Trait and Its Possible Cardioprotective Role
NCT02428023 ·Status: UNKNOWN
-
Correlation Between Pulmonary Functions and Physical Fitness in Children With β-thalassemia
NCT05494333 ·Status: UNKNOWN
-
Growth Evaluation, Health Promotion, and Clinical Management in Children and Adolescents With Thalassemia
NCT06931912 ·Status: RECRUITING ·Phase: NA
-
Evaluation of the Free α-hemoglobin Pool in the Red Blood Cells : Prognostic Marker and Severity Index in Thalassemic Syndromes
NCT02855957 ·Status: COMPLETED ·Phase: NA
-
The Effective and Safety of Thalidomide in TI
NCT03184844 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of Low Dose Thalidomide in Transfusion Dependent Thalassemia
NCT03651102 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Factors Promoting Increased Rate and Success of Pregnancy in the Thalassemia Population in Toronto
NCT00327639 ·Status: UNKNOWN
-
EKLF Gene Expression in β-thalassemia
NCT06440603 ·Status: NOT_YET_RECRUITING
-
A Study Evaluating the Safety and Efficacy of the GMCN-508A Drug Product in Transfusion-dependent α-Thalassemia Participants
NCT05757245 ·Status: RECRUITING ·Phase: PHASE1
-
Efficacy of Transdermal Microneedle Patch for Topical Anesthesia Enhancement in Paediatric Thalassemia Patients
NCT05078463 ·Status: COMPLETED ·Phase: PHASE2
-
Dermatological Abnormalities in Beta-thalassemia Major
NCT03894605 ·Status: UNKNOWN
-
Demographic, Clinical, Laboratory and Genetical Characteristics of Patients With Beta Thalassemia Intermedia
NCT01443312 ·Status: COMPLETED
-
Complications in Children With B- Thalassemia Major
NCT03462784 ·Status: UNKNOWN
-
Choroidal Thickness in Beta-thalassemia Patients
NCT04067258 ·Status: COMPLETED
-
Short-term Clinical Study of CN128 in Thalassemia Patients
NCT03935633 ·Status: COMPLETED ·Phase: PHASE1